廣譽遠(600771.SH):2021年度預虧3.30億元左右
格隆匯1月28日丨廣譽遠(600771.SH)公佈2021年年度業績預虧公吿,公司預計歸屬於上市公司股東的淨利潤為-3.30億元左右,與上年同期相比將減少3.62億元左右。預計歸屬於上市公司股東的扣除非經常性損益的淨利潤為-3.61億元左右,與上年同期相比將減少3.53億元左右。
業績預虧的主要原因:
1、受國內疫情零星散發不斷,終端藥店客流下降,為促進應收賬款清收和降低渠道庫存,公司根據市場客觀情況,結合產品在各區域的實際銷售情況,公司適當控制發貨,使得營業收入出現下滑。
2、受原材料價格普遍上漲的影響,以及不同毛利產品銷售結構佔比的變化,公司綜合毛利率較上年同期有所下降。
3、為了應對疫情影響客流下降,以及醫保控費、處方藥政策監管等不利影響,公司加大市場各類形式多樣的營銷活動投入,使得終端營銷、動銷費用和品牌建設費用投入持續加大,導致銷售費用大幅增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.